Without action, this could cause annual global GDP to fall by up to 3.8% before 2050
Vaccine development needs to play a vital role in combating anti-microbial resistance, argue Professor David Heymann and Abbas Omaar.
Abbas Omaar is a Research Assistant at the Centre on Global Health Security.